Department of Hospital Pharmaceutics, Showa University, Tokyo, Japan.
Department of Health Informatics, Kyoto University School of Public Health, Yoshida honcho sakyo-ku, Kyoto, Japan.
BMC Palliat Care. 2019 Jan 12;18(1):5. doi: 10.1186/s12904-019-0391-z.
Palliative care was a priority issue in the Cancer Control Act enacted in 2007 in Japan, and this has resulted in efforts being made toward educational goals in clinical settings. An investigation of how descriptions of palliative care for the treatment of cancer have changed in clinical practice guidelines (CPGs) could be expected to provide a better understanding of palliative care-related decision-making. This study aimed to identify trends in descriptions of palliative care in cancer CPGs in Japan before and after enactment of the Cancer Control Act.
Content analysis was used to count the lines in all relevant CPGs. We then compared the number of lines and the proportion of descriptions mentioning palliative care at two time points: the first survey (selection period: February to June 2007) and the second survey (selection period: February to December 2015). Descriptions from the CPGs were independently selected from the Toho University Medical Media Center and Medical Information Network Distribution Service databases, and subsequently reviewed, by two investigators.
Descriptions were analyzed for 10 types of cancer. The proportion of descriptions in the first survey (4.4%; 933/21,344 lines) was similar to that in the second survey (4.5%; 1325/29,269 lines).
After the enactment of the Cancer Control Act, an increase was observed in the number, but not in the proportion, of palliative care descriptions in Japanese cancer CPGs. In the future, CPGs can be expected to play a major role in helping cancer patients to incorporate palliative care more smoothly.
2007 年日本颁布的《癌症防治法》将缓和医疗作为优先事项,这促使临床环境朝着教育目标努力。对癌症临床实践指南(CPG)中描述的缓和医疗治疗方法的变化进行调查,有望更好地了解与缓和医疗相关的决策。本研究旨在确定日本癌症 CPG 中缓和医疗描述在《癌症防治法》颁布前后的变化趋势。
采用内容分析法计算所有相关 CPG 中的行数。然后,我们比较了两个时间点的行数和提及缓和医疗的描述比例:第一次调查(选择期:2007 年 2 月至 6 月)和第二次调查(选择期:2015 年 2 月至 12 月)。CPG 中的描述从独协医科大学医学媒体中心和医学信息网络分发服务数据库中独立选择,由两名研究人员进行审查。
分析了 10 种癌症的描述。第一次调查中的描述比例(4.4%;933/21344 行)与第二次调查相似(4.5%;1325/29269 行)。
《癌症防治法》颁布后,日本癌症 CPG 中缓和医疗描述的数量有所增加,但比例没有增加。今后,CPG 有望在帮助癌症患者更顺利地接受缓和医疗方面发挥重要作用。